Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

HIV Infection

Free Subscription 01.09.2025 2 AIDS 1 Antimicrob Agents Chemother 3 Clin Infect Dis 2 Int J Cancer 3 J Acquir Immune Defic Syndr 1 J Immunol 1 J Infect Dis 1 J Med Virol 2 J Virol 1 PLoS Biol 1 PLoS Med 6 PLoS One 1 PLoS Pathog 1 Proc Natl Acad Sci U S A 1 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. KAMPHUIS AEM, Kiezebrink T, Waalewijn H, Bamford A, et al
   Pharmacokinetics of lopinavir/ritonavir in second-line treatment of children living with HIV in the CHAPAS-4 trial.
   AIDS. 2025 Aug 26. doi: 10.1097/QAD.0000000000004328.
   PubMed         Abstract available
   
   
2. ZHAO H, Ye S, Lang G, Tang D, et al
   Serum triglyceride and high-density lipoprotein at admission are associated with 30-day overall mortality of patients with HIV and Talaromycosis.
   AIDS. 2025 Aug 26. doi: 10.1097/QAD.0000000000004327.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

3. LAI Y-T, Dingens AS, DeMouth M, Helmold Hait S, et al
   Fostemsavir analog BMS-818251 has enhanced viral neutralization potency and similar escape mutation profile.
   Antimicrob Agents Chemother. 2025 Aug 27:e0191024. doi: 10.1128/aac.01910.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

4. MAKUZA JD, Jeong D, Law M, Puyat JH, et al
   HBV Care Cascade in Rwanda: A Population-based Study From 2016-2023.
   Clin Infect Dis. 2025 Aug 29:ciaf393. doi: 10.1093.
   PubMed         Abstract available
   
   
5. FIGUEROA MI, Brites C, Cecchini D, Ramalho A, et al
   Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study.
   Clin Infect Dis. 2025 Aug 28:ciaf415. doi: 10.1093.
   PubMed         Abstract available
   
   
6. WATERS LJ
   DOLCE: Sweet Success for Dolutegravir/Lamivudine?
   Clin Infect Dis. 2025 Aug 28:ciaf416. doi: 10.1093.
   PubMed        
   
   

   
   Int J Cancer

7. ZHAO J, Zhang Y, Li K, Xu L, et al
   Estimates of global, regional, and national incidence of Hodgkin lymphoma attributable to Human Immunodeficiency virus: A population attributable modeling study.
   Int J Cancer. 2025 Aug 29. doi: 10.1002/ijc.70115.
   PubMed         Abstract available
   
   
8. FENG X, Patel EU, Kigozi G, Gravitt PE, et al
   Longitudinal patterns of penile human papillomavirus detection among Ugandan men: A prospective sampling study.
   Int J Cancer. 2025 Aug 25. doi: 10.1002/ijc.70107.
   PubMed         Abstract available
   
   

   
   J Acquir Immune Defic Syndr

9. FRIEDLAND BA, Browne EN, Roberts ST, Ngure K, et al
   Higher acceptability of the monthly dapivirine ring versus daily oral pre-exposure prophylaxis among adolescent girls and young women in sub-Saharan Africa in the REACH trial.
   J Acquir Immune Defic Syndr. 2025 Aug 28. doi: 10.1097/QAI.0000000000003756.
   PubMed         Abstract available
   
   
10. WANG H, Kolstee J, Gaetani M, Aphami L, et al
    Interest in and preference for long-acting injectable PrEP among men who have sex with men, trans* individuals, and cis-gender heterosexual women: a global systematic review and meta-analysis.
    J Acquir Immune Defic Syndr. 2025 Aug 27. doi: 10.1097/QAI.0000000000003754.
    PubMed         Abstract available
    
    
11. CHIROMBO J, Lora WS, Sakala D, Shahmanesh M, et al
    An exploratory study using respondent-driven sampling to map HIV risk across sex work locations in Blantyre, Malawi.
    J Acquir Immune Defic Syndr. 2025 Aug 26. doi: 10.1097/QAI.0000000000003746.
    PubMed         Abstract available
    
    

    
    J Immunol

12. D'ANTONIO MA, Ware BC, DiLisio JE, Michaels MJ, et al
    Lpar5 regulates the CD8 T-cell response to persistent virus infection by altering exhaustion programming, survival, and NK receptor expression.
    J Immunol. 2025 Aug 29:vkaf210. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Infect Dis

13. LABARILE M, Schoepf IC, Pasin C, Oumelloul MA, et al
    Untargeted Metabolite Profile Associations with Body Mass Index, Waist-Hip Ratio, and Antiretroviral Therapy in >1300 People with HIV: the Swiss HIV Cohort Study.
    J Infect Dis. 2025 Aug 27:jiaf438. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

14. POLITA D, de Moraes L, Giovanetti M, Rego FFA, et al
    South-to-Southeast Expansion of HIV-1 Subtype C in Brazil.
    J Med Virol. 2025;97:e70580.
    PubMed         Abstract available
    
    

    
    J Virol

15. CHATURBHUJ DN, Sliepen K, Cupo A, Steinberg B, et al
    A modification to heptad repeat 1 of gp41 improves yield and/or quality of soluble pre-fusion HIV-1 envelope glycoprotein trimers.
    J Virol. 2025 Aug 27:e0091325. doi: 10.1128/jvi.00913.
    PubMed         Abstract available
    
    
16. DAVIS DA, Astter Y, Treco EN, Shrestha P, et al
    Caspase cleavage of Kaposi sarcoma-associated herpesvirus proteins: a role for K5 in preventing caspase-mediated cell death during lytic replication.
    J Virol. 2025 Aug 29:e0062225. doi: 10.1128/jvi.00622.
    PubMed         Abstract available
    
    

    
    PLoS Biol

17. RAHEEM IT, Girijavallabhan V, Fillgrove KL, Goh SL, et al
    MK-8527 is a novel inhibitor of HIV-1 reverse transcriptase translocation with potential for extended-duration dosing.
    PLoS Biol. 2025;23:e3003308.
    PubMed         Abstract available
    
    

    
    PLoS Med

18. HUBER AN, Jamieson L, Fox MP, Manganye M, et al
    Evaluating the impact of differentiated service delivery (DSD) on retention in care and HIV viral suppression in South Africa: A target trial emulation using routine healthcare data.
    PLoS Med. 2025;22:e1004489.
    PubMed         Abstract available
    
    

    
    PLoS One

19. GUTIN SA, Mulauzi N, Jere J, Sungani C, et al
    "After reducing alcohol, things now work well at home": Perceived impacts of the Mlambe intervention on alcohol use, relationship dynamics, household economics, and HIV treatment adherence in Malawian couples.
    PLoS One. 2025;20:e0331202.
    PubMed         Abstract available
    
    
20. MWAKYANDILE TM, Shayo GA, Sasi PG, Kunambi PP, et al
    Low-dose aspirin is not effective as an adjunct treatment for HIV infection among people living with HIV on dolutegravir-based antiretroviral therapy: A randomised double-blind, parallel-group placebo-controlled trial.
    PLoS One. 2025;20:e0331087.
    PubMed         Abstract available
    
    
21. TUN NN, Smithuis F, Tun NL, Min M, et al
    Correction: Near point-of-care HIV viral load testing: Cascade after high viral load in suburban Yangon, Myanmar.
    PLoS One. 2025;20:e0331295.
    PubMed         Abstract available
    
    
22. SALAS-ORTIZ A, Opuni M, Figueroa JL, Masankha Banda L, et al
    The relationship between management practices and health facility performance: Evidence from low-resource, community-based facilities providing HIV services to key populations.
    PLoS One. 2025;20:e0330300.
    PubMed         Abstract available
    
    
23. JONES AD, Capriotti Z, Santos E, Lin A, et al
    HIV-1 controllers possess a unique CD8+ T cell activation phenotype and loss of control is associated with increased expression of exhaustion markers.
    PLoS One. 2025;20:e0328706.
    PubMed         Abstract available
    
    
24. SILVA JUNIOR JNB, Leal GDC, Ferreira QR, Andrade LKA, et al
    Effectiveness of tuberculosis preventive treatment on disease incidence among people living with HIV/AIDS: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0330208.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

25. 
    Retraction: Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease.
    PLoS Pathog. 2025;21:e1013442.
    PubMed        
    
    

    
    Proc Natl Acad Sci U S A

26. WAN Z, Li C, Zhou Y, Yu Y, et al
    Organoid-based neutralization assays reveal a distinctive profile of SARS-CoV-2 antibodies and recapitulate the real-world efficacy.
    Proc Natl Acad Sci U S A. 2025;122:e2509616122.
    PubMed         Abstract available
    
    

    
    Vaccine

27. BARLOW M, Flanagan S, Ghosh I, Carter J, et al
    Offering Hepatitis B vaccination to vulnerable populations: How can we plug the gaps?
    Vaccine. 2025;63:127639.
    PubMed        
    
    

    
    Virology

28. CHINNA P, Blumenthal MJ, Lambarey H, Jennings L, et al
    Assessment of gamma-herpesvirus infection dynamics in non-hospitalised people living with HIV during the COVID-19 pandemic in South Africa.
    Virology. 2025;611:110666.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.